February 13, 2018
A new report by Grandview Research suggests that global novel drug delivery systems (NDDS) in cancer therapies will reach $26.61...
May 23, 2017
OncBioMune Pharmaceuticals kicked off its formulation working with tretinoin in order to treat Acute Promyelocytic Leukemia.
April 20, 2017
OncBioMune Pharmaceuticals signs licensing agreement for rights to tretinoin, an oral drug for acute promyelocytic leukemia.